Synlogic, Inc. (OTCPK: SYBX)
Health Care · Biotechnology · US
$1.11
-0.89% today · -33.7% 1Y
Synlogic, Inc. (OTCPK: SYBX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $13.60M and employs 1 people.
Over the last twelve months the share price has lost 33.7%, trading between 0.54 and 1.87.
Tweenvest scores Synlogic, Inc. across four factors: quality 38/100, value 78/100. Its strongest factor is value.
SYBX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.60M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- 0.61
- 52-week high
- $1.87
- 52-week low
- $0.54
- Avg volume (3M)
- —
- Shares outstanding
- 12.25M
- Employees
- 1
- Next earnings
- —
About Synlogic, Inc.
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.
- ISIN
- US87166L2097
- Listed since
- Sep 30, 2015
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AEON Biopharma, Inc.NYSEAM: AEON | $13.92M | $0.30 | +8.75% |
| Initiator Pharma A/SOM: INIT | $13.85M | Skr1.74 | -14.29% |
| IN8bio, Inc.NasdaqCM: INAB | $13.80M | $1.40 | 0.00% |
| TME Pharma N.V.ENXTPA: ALTME | $13.67M | €0.12 | -5.86% |
| Niki BioSolutions, Inc.NasdaqCM: NIKI | $13.52M | $4.65 | +1.09% |
| Tempest Therapeutics, Inc.NasdaqCM: TPST | $13.42M | $0.78 | -3.78% |
| Aelis Farma SAENXTPA: AELIS | $13.39M | €0.88 | -4.89% |
| Passage Bio, Inc.NasdaqCM: PASG | $13.26M | $3.86 | -6.43% |
Figures last refreshed Oct 4, 2026.